Package Leaflet: Information for the Patient
Signifor0.3mg solution for injection
Signifor 0.6mgsolution for injection
Signifor 0.9mgsolution for injection
pasireotide
Read all of this leaflet carefully before you start using this medicine because it contains important information for you.
Contents of the pack
Signifor is a medicine that contains the active substance pasireotide. It is used to treat Cushing's disease in adult patients for whom surgery is not an option or for whom surgery has failed.
Cushing's disease is caused by an increase in the size of the pituitary gland (a gland located at the base of the brain) called a pituitary adenoma. This causes the body to produce too much of a hormone called adrenocorticotropic hormone (ACTH), which in turn causes an increase in the production of another hormone called cortisol.
The human body naturally produces a substance called somatostatin, which blocks the production of certain hormones, including ACTH. Pasireotide works in a very similar way to somatostatin. Signifor is therefore able to block the production of ACTH, helping to control the overproduction of cortisol and improve the symptoms of Cushing's disease.
If you have any questions about how Signifor works or why you have been prescribed this medicine, ask your doctor.
Do not use Signifor:
Warnings and precautions
Tell your doctor before you start using Signifor if you have or have had:
During your treatment with Signifor
Children and adolescents
Do not give this medicine to children and adolescents under 18 years of age because there is no data available for this age group.
Other medicines and Signifor
Signifor may affect the way other medicines work. If you are using other medicines at the same time as Signifor (including non-prescription medicines), your doctor may need to monitor your heart more closely or change the dose of Signifor or the other medicines. Tell your doctor or pharmacist if you are using, have recently used, or might use any other medicines. In particular, tell your doctor if you are using:
It is particularly important to tell your doctor if you are using:
Pregnancy, breast-feeding, and fertility
Ask your doctor or pharmacist for advice before taking any medicine.
Driving and using machines
Signifor may have a minor effect on your ability to drive and use machines, as some of the side effects you may experience while using Signifor, such as dizziness, headache, and tiredness, may reduce your ability to drive and use machines safely.
Important information about some of the ingredients of Signifor
Signifor contains less than 1 mmol of sodium (23 mg) per dose; this is essentially "sodium-free".
Follow exactly the instructions for administration of this medicine given by your doctor. If you are unsure, ask your doctor or pharmacist again. This medicine comes in an ampoule, which is a small glass container.
How much Signifor to use
The recommended dose is one ampoule of Signifor 0.6 mg twice a day. Using Signifor at the same time each day will help you remember when to use your medicine. After starting treatment, your doctor may decide to increase the dose to one ampoule of Signifor 0.9 mg twice a day.
If side effects occur, your doctor may temporarily reduce the dose by 0.3 mg per injection.
If you have liver disease before starting treatment with Signifor, your doctor may decide to start treatment with a dose of one ampoule of Signifor 0.3 mg twice a day.
Ampoules of Signifor of different strengths (0.3 mg, 0.6 mg, and 0.9 mg) are available to administer the specific dose prescribed by your doctor.
Your doctor will regularly check how you respond to treatment with Signifor and decide what dose is best for you.
How to use Signifor
Your doctor or nurse will teach you how to inject Signifor yourself. You should also read the instructions at the end of this leaflet. If you have any questions, contact your doctor, pharmacist, or nurse.
Signifor must be administered subcutaneously. This means it is injected with a short needle into the fatty tissue just under the skin. The thighs and abdomen are suitable areas for subcutaneous injection. Using a different site from the previous injection for each injection will help avoid pain and skin irritation. You should also avoid injecting into areas that are painful or where the skin is irritated.
Do not use Signifor if you notice that the solution is not clear or contains particles. The solution should be free of particles, clear, and colorless.
For how long to use Signifor
You should continue to use Signifor for as long as your doctor tells you.
If you use more Signifor than you should
If you have accidentally used more Signifor than your doctor prescribed, contact your doctor, pharmacist, or nurse immediately.
If you forget to use Signifor
Do not inject a double dose of Signifor to make up for forgotten doses. If you forget to inject a dose of Signifor, simply inject the next dose at the scheduled time.
If you stop using Signifor
If you stop using Signifor, your cortisol levels may increase again and your symptoms may return. Therefore, do not stop using Signifor unless your doctor tells you to.
If you have any other questions about using this medicine, ask your doctor, pharmacist, or nurse.
Like all medicines, this medicine can cause side effects, although not everybody gets them.
Some side effects may be serious. Tell your doctor immediately if you experience any of the following:
Very common (may affect more than 1 in 10 people)
Common (may affect up to 1 in 10 people)
Other side effects of Signifor may include:
Very common (may affect more than 1 in 10 people)
Common (may affect up to 1 in 10 people)
Uncommon (may affect up to 1 in 100 people)
Frequency not known (cannot be estimated from the available data)
Reporting of side effects
If you experience any side effects, talk to your doctor, pharmacist, or nurse, even if they are not listed in this leaflet. You can also report side effects directly through the national reporting system listed in Appendix V. By reporting side effects, you can help provide more information on the safety of this medicine.
Composition of Signifor
Signifor 0.3 mg: A 1 ml solution ampoule contains 0.3 mg of pasireotide (as pasireotide diaspartate).
Signifor 0.6 mg: A 1 ml solution ampoule contains 0.6 mg of pasireotide (as pasireotide diaspartate).
Signifor 0.9 mg: A 1 ml solution ampoule contains 0.9 mg of pasireotide (as pasireotide diaspartate).
Appearance of Signifor and Container Content
Signifor injectable solution is a clear and colorless solution in an ampoule. Each ampoule contains 1 ml of injectable solution.
Signifor is available in packs containing 6 ampoules or in multipacks containing 18 (3 packs of 6), 30 (5 packs of 6), or 60 (10 packs of 6) ampoules.
It is possible that, in your country, only some doses and some pack sizes are marketed.
Marketing Authorization Holder
Recordati Rare Diseases
Immeuble Le Wilson
70 avenue du Général de Gaulle
92800 Puteaux
France
Manufacturer
Novartis Pharma GmbH
Roonstrasse 25
D-90429 Nürnberg
Germany
Recordati Rare Diseases
Immeuble Le Wilson
70 avenue du Général de Gaulle
92800 Puteaux
France
Recordati Rare Diseases
Eco River Parc
30 rue des Peupliers
92000 Nanterre
France
You can request more information about this medicinal product by contacting the local representative of the marketing authorization holder:
Belgium/Belgique/Belgien Recordati Tel: +32 2 46101 36 | Lithuania Recordati AB. Tel: +46 8 545 80 230 Sweden |
Greece Recordati Rare Diseases Tel: +33 (0)1 47 73 64 58 France | Luxembourg/Luxemburg Recordati Tel: +32 2 46101 36 Belgium |
Czech Republic Recordati Rare Diseases Tel: +33 (0)1 47 73 64 58 France | Hungary Recordati Rare Diseases Tel: +33 (0)1 47 73 64 58 France |
Denmark Recordati AB. Tel: +46 8 545 80 230 Sweden | Malta Recordati Rare Diseases Tel: +33 1 47 73 64 58 France |
Germany Recordati Rare Diseases Germany GmbH Tel: +49 731 140 554 0 | Netherlands Recordati Tel: +32 2 46101 36 Belgium |
Estonia Recordati AB. Tel: +46 8 545 80 230 Sweden | Norway Recordati AB. Tel: +46 8 545 80 230 Sweden |
Greece Recordati Hellas Tel: +30 210 6773822 | Austria Recordati Rare Diseases Germany GmbH Tel: +49 731 140 554 0 Germany |
Spain Recordati Rare Diseases Spain S.L.U. Tel: +34 91 659 28 90 | Poland Recordati Rare Diseases Tel: +33 (0)1 47 73 64 58 France |
France Recordati Rare Diseases Tel: +33 (0)1 47 73 64 58 | Portugal Jaba Recordati S.A. Tel: +351 21 432 95 00 |
Croatia Recordati Rare Diseases Tel: +33 (0)1 47 73 64 58 France | Romania Recordati Rare Diseases Tel: +33 (0)1 47 73 64 58 France |
Ireland Recordati Rare Diseases Tel: +33 (0)1 47 73 64 58 France | Slovenia Recordati Rare Diseases Tel: +33 (0)1 47 73 64 58 France |
Iceland Recordati AB. Tel: +46 8 545 80 230 Sweden | Slovakia Recordati Rare Diseases Tel: +33 (0)1 47 73 64 58 France |
Italy Recordati Rare Diseases Italy Srl Tel: +39 02 487 87 173 | Finland Recordati AB. Tel: +46 8 545 80 230 Sweden |
Cyprus Recordati Rare Diseases Tel: +33 1 47 73 64 58 France | Sweden Recordati AB. Tel: +46 8 545 80 230 |
Latvia Recordati AB. Tel: +46 8 545 80 230 Sweden | United Kingdom Recordati Rare Diseases UK Ltd. Tel: +44 (0)1491 414333 |
Date of Last Revision of this Leaflet:
Other Sources of Information
Detailed information on this medicinal product is available on the European Medicines Agency website: http://www.ema.europa.eu. There are also links to other websites on rare diseases and orphan medicines.
INSTRUCTIONS FOR USE OF SIGNIFOR INJECTABLE SOLUTION
This medicinal product comes in an ampoule, i.e., a small glass container. Signifor must be administered using disposable syringes and needles for injection.
Your doctor or nurse will have given you instructions on how to use Signifor ampoules. However, before using the ampoule, read the following information carefully. If you are unsure about how to administer the injection yourself or if you have any doubts, contact your doctor or nurse for help.
The injection can be prepared using either two different needles for withdrawing and injecting the solution or a short fine needle for injection for these two steps. Based on local clinical practice, your doctor or nurse will inform you about which method to use. Please follow their instructions.
Store the Signifor ampoules according to the storage conditions indicated on the carton.
Important Safety Information
Caution: Keep the ampoules out of the reach of children.
What You Need
To inject yourself, you will need:
Injection Site
The injection site is the place on your body where the injection will be administered. Signifor is administered subcutaneously. This means it is injected using a short needle into the fatty tissue just under the skin. The thighs and abdomen are suitable areas for subcutaneous injection. Using a different site from the previous injection will avoid pain and irritation. You should also avoid injecting into areas that are painful or where the skin is irritated.
Preparation
When you are ready to administer the injection yourself, carefully follow the following steps:
To reduce local discomfort, it is recommended that the solution be kept at room temperature before administration.
The ampoules should be opened just before administration, and any unused portion should be discarded.
Check the Expiration Date and Dose
Check the expiration date on the ampoule label (after "EXP") and check that the ampoule contains the dose prescribed by your doctor.
DO NOT USE IT if the medicinal product has expired or if the dose is not correct. In both cases, return the complete package to the pharmacy.
How to Inject Signifor
Step 1: Signifor injectable solution is contained in a breakable ampoule. The colored dot on the top indicates the position of the break point on the neck of the ampoule. Gently tap the ampoule with your finger to ensure that there is no liquid in the top when you open it. |
Step 2: Recommended procedure: Hold the ampoule in a vertical position with the colored dot facing away from you. Hold the base of the ampoule in one hand. Keeping your thumbs together above and below the neck, break the top of the ampoule at the break point. Once the ampoule is open, place it in a vertical position on a clean and flat surface. |
Step 3: Take the sterile syringe and insert the needle. If you have been instructed to use two needles, you must use the long thick needle with a blunt tip for this step. Before proceeding with step 4, clean the injection site with a cotton swab. |
Step 4: Remove the needle cover. Insert the needle into the ampoule and pull the plunger to withdraw the complete contents of the ampoule into the syringe. If you have been instructed to use two needles, you must now replace the long needle with the short needle. |
Step 5: Hold the syringe in one hand between two fingers, placing your thumb on the bottom of the plunger. Gently tap the syringe with your fingers to eliminate air bubbles. Make sure there are no air bubbles in the syringe by pressing the plunger until the first drop appears at the tip of the needle. Do not let the needle touch anything. You are now ready for the injection. |
Step 6: Gently pinch the skin at the injection site and, keeping the needle at an angle of approximately 45 degrees (as shown in the figure), insert it into the injection site. Gently pull the plunger to check that you have not punctured a blood vessel. If you see blood in the syringe, first remove the needle from the skin, and then replace the short needle with a new one and insert it into a different injection site. |
Step 7: With the skin still pinched, slowly press the plunger to the end, injecting the entire solution. Keep the plunger pressed and the syringe in place for 5 seconds. |
Step 8: Slowly release the skin fold and gently remove the needle. Put the needle cover back on. |
Step 9: Immediately dispose of the used syringe and needle in a needle container or another rigid closed container for disposal. The disposal of unused medicinal product and all materials that have come into contact with it will be carried out in accordance with local regulations. |